Literature DB >> 25361799

Survivorship: screening for cancer and treatment effects, version 2.2014.

Crystal S Denlinger, Jennifer A Ligibel, Madhuri Are, K Scott Baker, Wendy Demark-Wahnefried, Don Dizon, Debra L Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H Ku, Elizabeth Kvale, Terry S Langbaum, Kristin Leonardi-Warren, Mary S McCabe, Michelle Melisko, Jose G Montoya, Kathi Mooney, Mary Ann Morgan, Javid J Moslehi, Tracey O'Connor, Linda Overholser, Electra D Paskett, Jeffrey Peppercorn, Muhammad Raza, M Alma Rodriguez, Karen L Syrjala, Susan G Urba, Mark T Wakabayashi, Phyllis Zee, Nicole R McMillian, Deborah A Freedman-Cass.   

Abstract

The NCCN Guidelines for Survivorship provide screening, evaluation, and treatment recommendations for common physical and psychosocial consequences of cancer and cancer treatment. This portion of the guidelines describes recommendations regarding screening for the effects of cancer and its treatment. The panel created a sample screening tool, specifically for use in combination with the NCCN Guidelines for Survivorship, to guide providers to topics that require more in-depth assessment. Effective screening and assessment can help providers deliver necessary and comprehensive survivorship care.
Copyright © 2014 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Year:  2014        PMID: 25361799      PMCID: PMC4771020          DOI: 10.6004/jnccn.2014.0152

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  6 in total

1.  Development and validation of the Short-Form Survivor Unmet Needs Survey (SF-SUNS).

Authors:  H Sharon Campbell; Alix E Hall; Rob W Sanson-Fisher; Daniel Barker; Donna Turner; Jill Taylor-Brown
Journal:  Support Care Cancer       Date:  2013-11-29       Impact factor: 3.603

2.  Cancer Rehabilitation Evaluation System (CARES) and CARES-SF now publicly available.

Authors:  Patricia A Ganz
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

3.  Assessing quality of life in adult cancer survivors (QLACS).

Authors:  Nancy E Avis; Kevin W Smith; Sarah McGraw; Roselyn G Smith; Vida M Petronis; Charles S Carver
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

4.  Measurement of the quality of life in cancer survivors.

Authors:  B R Ferrell; K H Dow; M Grant
Journal:  Qual Life Res       Date:  1995-12       Impact factor: 4.147

Review 5.  Measuring quality of life in cancer survivors: a methodological review of existing scales.

Authors:  Nancy J M Pearce; Rob Sanson-Fisher; H Sharon Campbell
Journal:  Psychooncology       Date:  2008-07       Impact factor: 3.894

Review 6.  A systematic review of quality of life instruments in long-term breast cancer survivors.

Authors:  Ishveen Chopra; Khalid M Kamal
Journal:  Health Qual Life Outcomes       Date:  2012-01-31       Impact factor: 3.186

  6 in total
  7 in total

1.  Cluster Analysis Demonstrates the Need to Individualize Care for Cancer Survivors.

Authors:  Belle H de Rooij; Elyse R Park; Giselle K Perez; Julia Rabin; Katharine M Quain; Don S Dizon; Kathryn E Post; Garrett M Chinn; Allison L McDonough; Rachel B Jimenez; Lonneke V van de Poll-Franse; Jeffrey Peppercorn
Journal:  Oncologist       Date:  2018-05-08

2.  Going Beyond Being Lost in Transition: A Decade of Progress in Cancer Survivorship.

Authors:  Larissa Nekhlyudov; Patricia A Ganz; Neeraj K Arora; Julia H Rowland
Journal:  J Clin Oncol       Date:  2017-04-24       Impact factor: 44.544

3.  Chemotherapy-Induced Neuropathy in Cancer Survivors.

Authors:  Christine Miaskowski; Judy Mastick; Steven M Paul; Kimberly Topp; Betty Smoot; Gary Abrams; Lee-May Chen; Kord M Kober; Yvette P Conley; Margaret Chesney; Kay Bolla; Grace Mausisa; Melissa Mazor; Melisa Wong; Mark Schumacher; Jon D Levine
Journal:  J Pain Symptom Manage       Date:  2017-01-04       Impact factor: 3.612

4.  Impact of chemotherapy-induced neurotoxicities on adult cancer survivors' symptom burden and quality of life.

Authors:  Christine Miaskowski; Judy Mastick; Steven M Paul; Gary Abrams; Steven Cheung; Jennifer Henderson Sabes; Kord M Kober; Mark Schumacher; Yvette P Conley; Kimberly Topp; Betty Smoot; Grace Mausisa; Melissa Mazor; Margaret Wallhagen; Jon D Levine
Journal:  J Cancer Surviv       Date:  2017-11-20       Impact factor: 4.442

5.  Signaling pathways and gene co-expression modules associated with cytoskeleton and axon morphology in breast cancer survivors with chronic paclitaxel-induced peripheral neuropathy.

Authors:  Kord M Kober; Mark Schumacher; Yvette P Conley; Kimberly Topp; Melissa Mazor; Marilynn J Hammer; Steven M Paul; Jon D Levine; Christine Miaskowski
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

6.  Body Misperception and Its Associated Factors among Cancer Survivors in Korea

Authors:  Hyun-Young Shin; Hee-Jin Hwang; Jaemin Kim
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26

7.  Quality of life of irradiated brain tumor survivors treated with donepezil or placebo: Results of the WFU CCOP research base protocol 91105.

Authors:  Michelle J Naughton; L Douglas Case; Ann Peiffer; Michael Chan; Volker Stieber; Dennis Moore; Steven Falchuk; James Piephoff; William Edenfield; Jeffrey Giguere; Monica Loghin; Edward G Shaw; Stephen R Rapp
Journal:  Neurooncol Pract       Date:  2017-07-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.